Mrs. Rachel P Stewart- Johnson, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 5 Garrett Ave, Post Office Box 1070, La Plata, MD 20646 Phone: 301-609-4285 Fax: 301-934-6958 |
Cassandra Griffin-weathers, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 5 Garrett Ave, La Plata, MD 20646 Phone: 301-609-4000 |
Mr. Rodolfo Bayle Ocampo, CRNA Nurse Anesthetist, Certified Registered Medicare: Not Enrolled in Medicare Practice Location: 701 E Charles St, Civista Medical Center, La Plata, MD 20646 Phone: 301-609-4152 |
Brandon Timothy Pace, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 5 Garrett Ave, La Plata, MD 20646 Phone: 301-609-4444 |
Ms. Ann Marie Buckler, C.R.N.A. Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 701 Charles St, La Plata, MD 20646 Phone: 301-609-4285 |
Mrs. Bronwyn Elizabeth Daugherty, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 701 Charles St, La Plata, MD 20646 Phone: 301-609-4000 |
April Lynn Myers, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 5 Garrett Ave, La Plata, MD 20646 Phone: 410-414-9229 |
Hailu Dame, Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 5 Garrett Ave, La Plata, MD 20646 Phone: 301-668-9988 |
News Archive
Orexo AB, the Swedish pharmaceutical company and Boehringer Ingelheim, the international pharmaceutical company headquartered in Ingelheim, Germany, have extended their existing three year research collaboration for a further 12 months from November 2008.
A new look at a large database of prostate cancer patients shows that obesity plays no favorites when it comes to increasing the risk of recurrence after surgery: Being way overweight is equally bad for blacks and whites, say researchers at Duke University Medical Center.
Researchers in Doernbecher Children's Hospital at Oregon Health & Science University will begin a Phase I clinical trial using stem cells in infants and children with a rare neurodegenerative disorder that affects infants and children.
AVEO Oncology (NASDAQ: AVEO) and Biodesix, Inc. today announced that they have entered into a worldwide agreement to develop and commercialize AVEO's hepatocyte growth factor (HGF) inhibitory antibody ficlatuzumab, with a Biodesix® companion diagnostic test.
Oxygen Biotherapeutics, Inc. today announced it has entered into a Cooperative Research and Development Agreement (CRADA) with the U.S. Naval Medical Research Center (NMRC) to conduct preclinical trials to assess the safety and efficacy of Oxygen Biotherapeutics' proprietary Oxycyte perfluorocarbon emulsion (PFCE) for the prevention and treatment of decompression sickness and related injuries.
› Verified 2 days ago